Procalcitonin Versus C-Reactive Protein for Guiding Antibiotic Therapy in Sepsis: A Randomized Trial*
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We sought to evaluate whether procalcitonin was superior to C-reactive protein in guiding antibiotic therapy in intensive care patients with sepsis. DESIGN: Randomized open clinical trial. SETTING: Two university hospitals in Brazil. PATIENTS: Patients with severe sepsis or septic shock. INTERVENTIONS: Patients were randomized in two groups: the procalcitonin group and the C-reactive protein group. Antibiotic therapy was discontinued following a protocol based on serum levels of these markers, according to the allocation group. The procalcitonin group was considered superior if the duration of antibiotic therapy was at least 25% shorter than in the C-reactive protein group. For both groups, at least seven full-days of antibiotic therapy were ensured in patients with Sequential Organ Failure Assessment greater than 10 and/or bacteremia at inclusion, and patients with evident resolution of the infectious process had antibiotics stopped after 7 days, despite biomarkers levels. MEASUREMENTS AND MAIN RESULTS: Ninety-four patients were randomized: 49 patients to the procalcitonin group and 45 patients to the C-reactive protein group. The mean age was 59.8 (SD, 16.8) years. The median duration of antibiotic therapy for the first episode of infection was 7.0 (Q1-Q3, 6.0-8.5) days in the procalcitonin group and 6.0 (Q1-Q3, 5.0-7.0) days in the C-reactive protein group (p=0.13), with a hazard ratio of 1.206 (95% CI, 0.774-1.3; p=0.13). Overall, protocol overruling occurred in only 13 (13.8%) patients. Twenty-one patients died in each group (p=0.836). CONCLUSIONS: C-reactive protein was as useful as procalcitonin in reducing antibiotic use in a predominantly medical population of septic patients, causing no apparent harm.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 1×
“The early and empirical initiation of antibiotic treatment is recommended for patients with suspected severe bacterial infection and is associated with lower mortality (2, 3).”
Background2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients
Ferreira, F. L. (2001) · JAMA · doi:10.1001/jama.286.14.1754 · Cited by 2,862 · cited 1×
“The inclusion of the SOFA score sought to increase patient safety (39).”
BackgroundBouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032
Schuetz, P., Christ-Crain, M., Thomann, R., Falconnier, C., Wolbers, M., Widmer, I., Neidert, S., Fricker, T., Blum, C., Schild, U., et al. (2009) · JAMA · doi:10.1001/jama.2009.1297 · Cited by 959
Cited by
Items 101–200 of 215
Welche Biomarker zu Diagnosestellung und Steuerung der antiinfektiven Therapie bei Sepsis?
Ehler, J., Busjahn, C., & Schürholz, T. (2021) · Der Anaesthesist · doi:10.1007/s00101-021-01067-7 · Cited by 17
Biomarkers: Are They Useful in Severe Community-Acquired Pneumonia?
Póvoa, P. M. S. R., Pitrowsky, M. T., Guerreiro, G., Pacheco, M. B., & Salluh, J. I. (2024) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0043-1777771 · Cited by 13
Salluh, J. I., Junior, V. A. N., & Póvoa, P. M. S. R. (2014) · Critical Care · doi:10.1186/cc13870 · Cited by 14
Lam, S. W., Bauer, S. R., & Duggal, A. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.10.017 · Cited by 14
Procalcitonin-guided antibiotic treatment in critically ill patients
Höhn, A., Heising, B., Schütte, J.-K., Schroeder, O., & Schröder, S. (2016) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-016-1458-4 · Cited by 14
Park, D. W., Choi, J. Y., Kim, C.-J., Kim, J. H., Kim, H. B., & Lee, D. (2022) · Infection and Chemotherapy · doi:10.3947/ic.2022.0170 · Cited by 15
How to optimise duration of antibiotic treatment in patients with sepsis?
Hellyer, T. P., Mantle, T., McMullan, R., & Dark, P. M. (2020) · BMJ · doi:10.1136/bmj.m4357 · Cited by 12
Heilmann, E., Gregoriano, C., Annane, D., Reinhart, K., Bouadma, L., Wolff, M., Chastre, J. E., Luyt, C. E., Tubach, F., Branche, A. R., et al. (2021) · Age and Ageing · doi:10.1093/ageing/afab078 · Cited by 15
Self-citationImai, Y., Tanaka, R., Honda, K., Matsuo, K., Taniguchi, K., Asakuma, M., & Lee, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-24780-8 · Cited by 12
New Biomarkers of Sepsis with Clinical Relevance
Cunha, D. M. G., da Silva, G. G., & Hamasaki, M. Y. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.82156 · Cited by 13
Jönsson, N., Gille-Johnson, P., Martling, C., Xu, S., Venge, P., & Mårtensson, J. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.07.001 · Cited by 12
Einsatz von Biomarkern in der Sepsis: Update und Ausblick
Siegler, B. H., Weiterer, S., Lichtenstern, C., Stumpp, D., Brenner, T., Hofer, S., Weigand, M. A., & Uhle, F. (2014) · Der Anaesthesist · doi:10.1007/s00101-014-2347-2 · Cited by 13
Huttner, A., Albrich, W. C., Bochud, P., Gayet‐Ageron, A., Rossel, A., von Dach, E., Harbarth, S., & Kaiser, L. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017996 · Cited by 12
Bracho‐Blanchet, E., Domínguez-Muñóz, A., Fernández-Portilla, E., Zalles-Vidal, C., & Dávila-Pérez, R. (2017) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2017.07.006 · Cited by 11
Biomarkers in sepsis: can they help improve patient outcome?
Kyriazopoulou, E., Poulakou, G., & Giamarellos‐Bourboulis, E. J. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000707 · Cited by 11
Do we need new trials of procalcitonin-guided antibiotic therapy?
Lisboa, T. C., Salluh, J. I., & Póvoa, P. M. S. R. (2018) · Critical Care · doi:10.1186/s13054-018-1948-6 · Cited by 11
ESTRATEGIAS PARA EL USO DE ANTIBIÓTICOS EN PACIENTES CRÍTICOS
Arancibia, J. M. (2019) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2019.03.001 · Cited by 18
Habr, B., Saliba, Y., Hajal, J., Smayra, V., Riachy, M. A., & Farès, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118366 · Cited by 10
Ammar, A. A., Lam, S. W., Duggal, A., Neuner, E. A., Bass, S. N., Guzmán, J. A., Wang, X., Han, X., & Bauer, S. R. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1887 · Cited by 10
Biomarkers in Pulmonary Infections
Póvoa, P. M. S. R., Coelho, L., & Bos, L. D. J. (2019) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000322 · Cited by 10
Major publications in the critical care pharmacotherapy literature: January–December 2013
Rech, M. A., Day, S. A., Kast, J. M., Donahey, E. E., Pajoumand, M., Kram, S. J., Erdman, M. J., Peitz, G. J., Allen, J. M., Palmer, A. E., et al. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140241 · Cited by 10
To which extent can we decrease antibiotic duration in critically ill patients?
Garnacho‐Montero, J., Arenzana, Á., Waele, J. J. D., & Kollef, M. H. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1369879 · Cited by 11
Role of biomarkers in antimicrobial stewardship: physicians’ perspectives
Seok, H., & Park, D. W. (2024) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2023.558 · Cited by 13
New biomarkers for respiratory infections
Póvoa, P. M. S. R., Coelho, L., & Bos, L. D. J. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000669 · Cited by 11
Procalcitionin as a diagnostic marker to distinguish upper and lower gastrointestinal perforation
Gao, Y., Yu, K., Kang, K., Liu, H.-T., Zhang, X. Y., Huang, R., Qu, J.-D., Wang, S.-C., Liu, R., Liu, Y., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i24.4422 · Cited by 9
Marin, M. J., van Wijk, X. M. R., & Chambliss, A. B. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.02.003 · Cited by 10
Utility of procalcitonin in a medical intensive care unit in Croatia
Brajković, A. V., Košuta, I., Tomek, D., Rora, M., Babel, J., Rogić, D., Vrančić, A. L., & Radonić, R. (2020) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01747-1 · Cited by 7
August, B., Kale-Pradhan, P. B., Giuliano, C. A., & Johnson, L. B. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2834 · Cited by 9
The Diagnostic Accuracy of Serum Procalcitonin for Bacteremia in Critically Ill Children
Nellis, M. E., Pon, S., Giambrone, A. E., Coleman, N. E., Reiss, J. D., Mauer, E. A., & Greenwald, B. M. (2016) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000432 · Cited by 7
Rabello, L. S. C. F., Póvoa, P. M. S. R., Silva, J. R. L. E., Azevedo, L. C. P., Ramos, F. J. D. S., Lisboa, T. C., Soares, M., & Salluh, J. I. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.07.021 · Cited by 7
Procalcitonin-Guided Antibiotic Therapy Duration in Critically Ill Adults
Walker, C. (2015) · AACN Advanced Critical Care · doi:10.1097/nci.0000000000000079 · Cited by 7
Any Role for Biomarker-Guide Algorithms in Antibiotic Stewardship Programs?*
Póvoa, P. M. S. R., & Kalil, A. C. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004295 · Cited by 7
Gu, Q., Yuan, K. Z., Wei, J., Yoon, C. H., Danielsen, A. S., Luk, A., Eyre, D. W., & Walker, A. S. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11381-9 · Cited by 6
Antibiotics for Intra-Abdominal Infections: When, Which, How and How Long?
Sartelli, M., Palmieri, M., & Labricciosa, F. M. (2025) · Antibiotics · doi:10.3390/antibiotics14111127 · Cited by 8
Kwa, A. L., Sidharta, B. R. A., Son, D. N., Zirpe, K. G., Periyasamy, P. R., Plongla, R., Swaminathan, S., Loho, T., Vu, G. V., & Apisarnthanarak, A. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2296066 · Cited by 7
Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship
Pardo, J. R. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810477-4.00006-4 · Cited by 7
de Rezende, V. M. L. R., Borges, I. N., Ravetti, C. G., de Souza, R. P., Vassallo, P. F., Caldas, A. C. D. P., Gatto, F. R., Okamura, G. H., Lacerda, R. L. D. B., Póvoa, P. M. S. R., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-084981 · Cited by 8
Cost-effectiveness of procalcitonin-guided antibiotic duration for hospitalized patients with sepsis
Stevenson, M., Forsyth, J. E., Hossain, A., Lall, R., Dark, P. M., collaborators, A.-S., Carlson, G., Naisbitt, M. J., Kay, D., Barber, S., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05732-w · Cited by 10
Yukumi, S., Ishimaru, K., Suzuki, H., Abe, M., Morimoto, M., Senba, M., Yamamoto, T., Mori, Y., Sakao, N., & Sano, Y. (2022) · Respiratory Investigation · doi:10.1016/j.resinv.2022.11.001 · Cited by 5
Permana, S. A., Purwoko, P., & Hartono, E. J. (2024) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2024.31.5.3 · Cited by 5
Leukemoid like reaction in a post CABG patient
Padmakumar, G., Ravikrishnan, J., Jayakumar, P., & Prasad, R. K. (2014) · Indian Journal of Anaesthesia · doi:10.4103/0019-5049.135046 · Cited by 5
Personalized Approaches to Patients with Intra-Abdominal Infections
Sartelli, M., Coccolini, F., Labricciosa, F. M., Siquini, W., Pipitone, G., Palmieri, M., Sbacco, V., Vallicelli, C., Marmorale, C., & Catena, F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217774 · Cited by 5
Biomarker-guided antibiotic cessation in sepsis: evidence and future challenges
Claxton, A., & Dark, P. M. (2018) · British Journal of Hospital Medicine · doi:10.12968/hmed.2018.79.3.136 · Cited by 4
Diagnostik der Sepsis – Teil 1: allgemeine Diagnostik und Fokussuche-/sanierung
Richter, D., Heininger, A., Schmidt, K., Schmoch, T., Bernhard, M. H., Mayer, P., Weigand, M. A., & Brenner, T. (2019) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-0625-5507 · Cited by 8
Gregoriano, C., Wirz, Y., Heinsalo, A., Annane, D., Reinhart, K., Bouadma, L., Christ‐Crain, M., Kristoffersen, K. B., Damas, P., Junior, V. A. N., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-13160-2 · Cited by 5
Self-citationThe CRP/PAB ratio outperforms the LRINEC score in early diagnosis of Fournier's gangrene
Zhu, J., Gao, H.-J., & Yin, Z.-T. (2024) · Surgery in Practice and Science · doi:10.1016/j.sipas.2024.100267 · Cited by 3
The Use of Biomarkers to Track and Treat Critical Illness
Goggs, R. A. N. (2025) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2025.01.010 · Cited by 3
Johari, T., & Chicco, D. (2026) · Discover Computing · doi:10.1007/s10791-026-09974-2 · Cited by 2
Procalcitonin and New Biomarkers
Mir, N. A., Ho, D., Toews, J. R., & Walsham, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-64774-6_5 · Cited by 2
de Barros, G. M., Borges, I. N., Ravetti, C. G., Diniz, P. H., Ferreira, S. R., Mori, L. H. D., Castro, R., Okamura, G. H., Gatto, F. R., Junior, V. A. N., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09544-1 · Cited by 2
Using Procalcitonin in Septic Shock to Guide Antibacterial Therapy
Sullivan, S. M., & Rueden, K. T. V. (2016) · Dimensions of Critical Care Nursing · doi:10.1097/dcc.0000000000000164 · Cited by 5
[Association of inflammatory indices with the severity of urinary sepsis: analysis of 70 cases].
Tan, L., Yang, C., Yang, X., Wang, Y., Cai, G., Cao, Z., Huang, C., & Xu, D. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.01.15 · Cited by 3
Procalcitonin Is Not an Adequate Tool for Antimicrobial De-Escalation in Sepsis
Maves, R. C. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004547 · Cited by 2
Jafari, M., Fazeli, F., Sezavar, M., Khashkhashi, S., Fazli, B., Abdollahpour, N., & Sedaghat, A. (2021) · PubMed Central · Cited by 2
Abdelrahman, E. A., Abdelazeem, E., Heikal, A. T., & Rezk, E. F. (2024) · The Egyptian Journal of Critical Care Medicine · doi:10.1007/s44349-024-00005-x · Cited by 1
ANTIBACTERIAL THERAPY IN SEPSIS PATIENTS
Shapoval, С. D. (2024) · Art of Medicine · doi:10.21802/artm.2024.3.31.263 · Cited by 1
Albin, O. R., Nadimidla, S., Saravolatz, L. I. I., Barker, A., Wayne, M. T., Rockney, D., Jean, R. A., Nguyen, A., Diwan, M., Pierce, V., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-110019 · Cited by 1
Shan, J., Gao, Y., Su, J., Xu, R., Zhang, C., Fu, Y., & Wang, G. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-06282-4 · Cited by 1
Duration of antibiotic therapy: with or without biomarkers?
Guerreiro, G., Fustiga, J., & Póvoa, P. M. S. R. (2026) · Acute and Critical Care · doi:10.4266/acc.002525 · Cited by 1
Raja, H. A. A., Afridi, M. K., Asad, F., Yasin, K., Uzair, M., Saleem, Y., Sardar, H., Bismil, I., Saeed, A., Ullah, I., et al. (2026) · Medical Principles and Practice · doi:10.1159/000551475 · Cited by 1
Potentials of novel sepsis diagnostic biomarker in intensive care unit: Systematic review
Eldein, M. M. N. (2026) · Journal of Umm Al-Qura University for Medical Sciences · doi:10.1007/s44361-025-00014-0 · Cited by 1
Gestion de la durée de l’antibiothérapie selon les résultats des biomarqueurs
Quenot, J., Large, A., Dargent, A., Andreu, P., Bruyère, R., Barbar, S. D., & Charles, P. (2016) · Réanimation · doi:10.1007/s13546-016-1180-9 · Cited by 1
Impact of Bedside Tracheostomy on Procalcitonin Kinetics in Critically Ill Patients
Sato, K., Okajima, M., Noda, T., & Taniguchi, T. (2017) · Journal of Intensive Care Medicine · doi:10.1177/0885066617696845 · Cited by 1
Peny, V., Månsson, F., Resman, F., Ahl, J., & Tham, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186514 · Cited by 2
Antibiotic Stewardship in der Intensivmedizin
Juzek-Küpper, M. F., Fussen, R., Haverkamp, M. R., & Lemmen, S. (2018) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0042-109253 · Cited by 1
Ryoo, S. M., Yoo, S. J., Kim, J. S., Yu, G., Jung, S. M., Kim, Y., Sohn, C. H., & Kim, W. Y. (2018) · Therapeutic Hypothermia and Temperature Management · doi:10.1089/ther.2018.0033 · Cited by 1
The Use of Biomarkers to Track and Treat Critical Illness
Goggs, R. A. N. (2023) · Advances in Small Animal Care · doi:10.1016/j.yasa.2023.07.001 · Cited by 1
Wang, C., Sun, T., Zhou, Y., Liu, T., Feng, S., Xiong, X., Fan, J., Liang, Q., Cui, Y., & Zhang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38728 · Cited by 1
ESR and CRP: it is time to stop the zombie tests: author's response
Spellberg, B. J., Ghanem, B., Boyles, T. H., Lee, T. C., & McDonald, E. G. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.09.029 · Cited by 1
Désescalade de l’antibiothérapie en réanimation
Razazi, K., & Brun‐Buisson, C. (2014) · Réanimation · doi:10.1007/s13546-014-0865-1 · Cited by 1
OLIVEIRA, D. E., Cunha, E. G. C., GUERRA, D. M., & Bezerra, V. S. (2021) · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde · doi:10.30968/rbfhss.2021.122.0563 · Cited by 1
Procalcitonin or C-Reactive Protein
Corona, A., & Iaco, M. D. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000116 · Cited by 1
Trials of Biomarker-Guided Antimicrobial Therapy in Sepsis
Salluh, J. I., & Póvoa, P. M. S. R. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000013 · Cited by 1
Re: ‘ESR and CRP: it's time to stop the zombie tests’ by Spellberg et al.
Huttner, A., Tamma, P. D., & Yahav, D. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.09.016 · Cited by 2
Zimmerman, J. J. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001323
Narrowing in on Early Cystic Fibrosis Lung Disease
Fa, B., Cr, O., Ks, R., & Harrigan, P. (2014)
Usage de la procalcitonine pour guider l’utilisation des antibiotiques en cas de sepsis
Tran, L., Ferland, C., & Ang, A. (2016) · Pharmactuel · Cited by 1
Yoshitaka, H. A. R. A., & Nishida, O. (2017) · THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA · doi:10.2199/jjsca.37.811
Research progress on anti-infection therapy for sepsis in children
Guoxiu, L. (2018) · Infection International/Infection International (Electronic Edition) · doi:10.2478/ii-2018-0018
真知, 柳., 淳, 江., 茂樹, 藤., 津久田純平, 由佳, 高., 健一郎, 森., & 泰彦, 平. (2018) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.1002/jja2.12282
Antimicrobial Stewardship in Sepsis
Plata-Menchaca, E. P., Esteban, E., & Ferrer, R. (2019) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-030-06067-1_39 · Cited by 1
Collaborating with the Microbiology Laboratory
Forrest, G. N., & Kirsch, D. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316694411.010
국진주 (2018) · YUHSpace (Yonsei University Medical Library)
Antibiotic Stewardship (ABS) im Krankenhaus: ein Update
Juzek-Küpper, M. F., & Lemmen, S. (2022) · Krankenhaushygiene up2date · doi:10.1055/a-1546-7636 · Cited by 1
Junior, V. A. N., Oliveira, C. F., & de Oliveira, C. R. A. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000069
Self-citationEley, B. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733115458.793555857
Junior, V. A. N., Oliveira, C. F., & de Oliveira, C. R. A. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000178
Self-citationVincent, J., & Lelubre, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-73506-1_6 · Cited by 1
Sepsis: Molecular Diagnostics and Biomarkers
Lyons, J. D., & Coopersmith, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88271-2.00001-8
Allmon, A., Marshall, B., Gutierrez, M., & Ash, A. (2023) · Evidence-Based Practice · doi:10.1097/ebp.0000000000002050
Hartono, E. J., Permana, S. A., & Pratama, V. K. P. (2024) · Journal of Acute Care · doi:10.5005/jp-journals-10089-0080
Sasidharan, S. (2025) · Journal of Medical Sciences · doi:10.4103/jmedsci.jmedsci_49_25
Lien, F., Lin, H.-S., Wu, Y.-T., & Chiueh, T.-S. (2022) · Figshare · doi:10.6084/m9.figshare.19450992
Borges, I. N., Carneiro, R. M., Bergo, R., Martins, L., Colosimo, E. A., Oliveira, C., Saturnino, S. F., de Andrade, M. V. M., Ravetti, C., & Junior, V. A. N. (2020) · Figshare · doi:10.6084/m9.figshare.12414728
Self-citationBorges, I. N., Carneiro, R. M., Bergo, R., Martins, L., Colosimo, E. A., Oliveira, C., Saturnino, S. F., de Andrade, M. V. M., Ravetti, C., & Junior, V. A. N. (2020) · Figshare · doi:10.6084/m9.figshare.12414746
Self-citationLi, C.-H., Seak, C.-J., Chaou, C.-H., Su, T., Gao, S.-Y., Chien, C.-Y., & Ng, C.-J. (2022) · Figshare · doi:10.6084/m9.figshare.17869911
Borges, I. N., Carneiro, R. M., Bergo, R., Martins, L., Colosimo, E. A., Oliveira, C., Saturnino, S. F., de Andrade, M. V. M., Ravetti, C., & Junior, V. A. N. (2020) · Figshare · doi:10.6084/m9.figshare.12414758
Self-citationLi, C.-H., Seak, C.-J., Chaou, C.-H., Su, T., Gao, S.-Y., Chien, C.-Y., & Ng, C.-J. (2022) · Figshare · doi:10.6084/m9.figshare.17869908
Borges, I. N., Carneiro, R. M., Bergo, R., Martins, L., Colosimo, E. A., Oliveira, C., Saturnino, S. F., de Andrade, M. V. M., Ravetti, C., & Junior, V. A. N. (2020) · Figshare · doi:10.6084/m9.figshare.12414749
Self-citationBorges, I., Carneiro, R. M., Bergo, R., Martins, L., Colosimo, E. A., Oliveira, C., Saturnino, S. F., de Andrade, M. V. M., Ravetti, C., & Junior, V. A. N. (2020) · Figshare · doi:10.6084/m9.figshare.12414731
Self-citation
Metadata
- Authors
- Oliveira, C. F., Botoni, F. A., Oliveira, C. R. A., Silva, C. B., Pereira, H. A., Serufo, J. C., & Nobre, V.
- Affiliations
- Universidade Federal de Minas Gerais (BR)
- Venue
- Critical Care Medicine
- Published
- 2013-10
- Volume
- 41
- Issue
- 10
- Pages
- 2336-2343
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2079018559
- Semantic Scholar
- 3891d0cdee5f3e4ad39527256fb686aa6935d02c
- Cited by
- 213
- References
- 38
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 24 · 2023: 14 · 2022: 19 · 2021: 13 · 2020: 25 · 2019: 14 · 2018: 23 · 2017: 19 · 2016: 14 · 2015: 10 · 2014: 14 · 2013: 1
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Universidade Federal de Minas Gerais
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- procalcitonin, C-reactive protein, sepsis, septic shock, antibiotic stewardship, antibiotic duration, biomarkers, intensive care unit patients, bacteremia
- MeSH terms
- Aged, Anti-Bacterial Agents, Brazil, C-Reactive Protein, Calcitonin, Female, Hospitals, University, Humans, Intensive Care Units, Male, Middle Aged, Protein Precursors, Shock, Septic, Biomarkers, Calcitonin Gene-Related Peptide, Confidence Intervals, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.